- Home
- TMO vs BX Comparison
TMO vs BX Comparison
Compare TMO & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TMO | BX |
|---|---|---|
| Founded | 1956 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.8B | 149.5B |
| IPO Year | 1996 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TMO | BX |
|---|---|---|
| Price | $473.12 | $124.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 17 |
| Target Price | ★ $636.00 | $156.53 |
| AVG Volume (30 Days) | 1.9M | ★ 5.4M |
| Earning Date | 04-23-2026 | 04-23-2026 |
| Dividend Yield | 0.40% | ★ 3.96% |
| EPS Growth | ★ 7.32 | 6.91 |
| EPS | ★ 4.43 | 3.87 |
| Revenue | ★ $20,918,000,000.00 | $14,450,265,000.00 |
| Revenue This Year | $6.55 | $12.40 |
| Revenue Next Year | $5.11 | $23.10 |
| P/E Ratio | $105.34 | ★ $31.79 |
| Revenue Growth | ★ 14.47 | 9.22 |
| 52 Week Low | $385.46 | $101.73 |
| 52 Week High | $643.99 | $190.09 |
Technical Indicators
Market Signals| Indicator | TMO | BX |
|---|---|---|
| Relative Strength Index (RSI) | 42.41 | 54.81 |
| Support Level | $454.22 | $104.00 |
| Resistance Level | $497.64 | $134.87 |
| Average True Range (ATR) | 13.24 | 4.11 |
| MACD | -2.90 | -0.30 |
| Stochastic Oscillator | 19.96 | 43.34 |
Price Performance
Historical ComparisonAbout TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
About BX Blackstone Inc.
Blackstone is the world's largest alternative-asset manager with $1.275 trillion in total assets under management, including $921.7 billion in fee-earning assets under management, at the end of 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), credit and insurance (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).